common.study.topics.clinical

TDM Guided Early Optimization of ADAL in Crohn's Disease

common.study.values.description

“TDM Guided Early Optimization of ADAL in Crohn's Disease”

To investigate the influence of early therapeutic drug monitoring and dose optimization on disease outcome in Crohn's patients treated with Adalimumab.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

Biological - Adalimumab

participant.views.study.view.additional

participant.views.study.view.scientific-title

Therapeutic Drug Monitoring Guided Early Optimization of Adalimumab in Crohn's Disease; A Randomized Open Label Study

common.study.values.clinical-trial-id

NCT03261102

participant.views.study.view.id

mbk4xd